Global On-body Injectors Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Semiconductor Pedestals market size is predicted to grow from US$ 521 million in 2025 to US$ 702 million in 2031; it is expected to grow at a CAGR of 5.1% from 2025 to 2031.
This studies the semiconductor pedestals, covers the metal pedestals and ceramic pedestals, used for electrostatic chucks and wafer heaters, etc.
Semiconductor manufacturing equipment is a medium tool for achieving semiconductor manufacturing processes, playing an important role in all aspects. According to SEMI, worldwide sales of semiconductor manufacturing equipment increased 5% from $102.6 billion in 2021 to an all-time record of $107.6 billion in 2022.
In recent years, the localization process of China's semiconductor industry has further accelerated, and the performance of semiconductor equipment is more flexible than the overall industry. The localization of semiconductor equipment is ushering in a golden wave, and domestic semiconductor equipment is facing more opportunities for verification and trial use, technical cooperation, and import substitution. For the third consecutive year, China remained the largest semiconductor equipment market in 2022 despite a 5% slowdown in the pace of investments in the region year over year, accounting for $28.3 billion in billings.
The record high for semiconductor manufacturing equipment sales in 2022 stems from the industry’s drive to add the fab capacity required to support long-term growth and innovations in key end markets including high-performance computing and automotive. Additionally, the results reflect investments and determination across regions to avoid future semiconductor supply chain constraints like those that surfaced during the pandemic.
LP Information, Inc. (LPI) ' newest research report, the “Semiconductor Pedestals Industry Forecast” looks at past sales and reviews total world Semiconductor Pedestals sales in 2024, providing a comprehensive analysis by region and market sector of projected Semiconductor Pedestals sales for 2025 through 2031. With Semiconductor Pedestals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Semiconductor Pedestals industry.
This Insight Report provides a comprehensive analysis of the global Semiconductor Pedestals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Semiconductor Pedestals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Semiconductor Pedestals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Semiconductor Pedestals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Semiconductor Pedestals.
This report presents a comprehensive overview, market shares, and growth opportunities of Semiconductor Pedestals market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Semiconductor Pedestals market?
What factors are driving Semiconductor Pedestals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Semiconductor Pedestals market opportunities vary by end market size?
How does Semiconductor Pedestals break out by Type, by Application?
The global Semiconductor Pedestals market size is predicted to grow from US$ 521 million in 2025 to US$ 702 million in 2031; it is expected to grow at a CAGR of 5.1% from 2025 to 2031.
This studies the semiconductor pedestals, covers the metal pedestals and ceramic pedestals, used for electrostatic chucks and wafer heaters, etc.
Semiconductor manufacturing equipment is a medium tool for achieving semiconductor manufacturing processes, playing an important role in all aspects. According to SEMI, worldwide sales of semiconductor manufacturing equipment increased 5% from $102.6 billion in 2021 to an all-time record of $107.6 billion in 2022.
In recent years, the localization process of China's semiconductor industry has further accelerated, and the performance of semiconductor equipment is more flexible than the overall industry. The localization of semiconductor equipment is ushering in a golden wave, and domestic semiconductor equipment is facing more opportunities for verification and trial use, technical cooperation, and import substitution. For the third consecutive year, China remained the largest semiconductor equipment market in 2022 despite a 5% slowdown in the pace of investments in the region year over year, accounting for $28.3 billion in billings.
The record high for semiconductor manufacturing equipment sales in 2022 stems from the industry’s drive to add the fab capacity required to support long-term growth and innovations in key end markets including high-performance computing and automotive. Additionally, the results reflect investments and determination across regions to avoid future semiconductor supply chain constraints like those that surfaced during the pandemic.
LP Information, Inc. (LPI) ' newest research report, the “Semiconductor Pedestals Industry Forecast” looks at past sales and reviews total world Semiconductor Pedestals sales in 2024, providing a comprehensive analysis by region and market sector of projected Semiconductor Pedestals sales for 2025 through 2031. With Semiconductor Pedestals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Semiconductor Pedestals industry.
This Insight Report provides a comprehensive analysis of the global Semiconductor Pedestals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Semiconductor Pedestals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Semiconductor Pedestals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Semiconductor Pedestals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Semiconductor Pedestals.
This report presents a comprehensive overview, market shares, and growth opportunities of Semiconductor Pedestals market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Metal Pedestal
- Ceramic Pedestal
- 300mm System
- 200mm System
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Applied Materials (AMAT)
- Lam Research
- Technetics Semi
- Therm-x
- Cast Aluminum Solutions (CAS)
- Durex Industries
- Watlow (CRC)
- Backer AB
- BoBoo Hitech
- CoorsTek
- SemiXicon
- NGK Insulators (NTK Ceratec)
- Kyocera
- Shinko Electric Industries
- TOTO
- II-VI
- AK Tech Co.,Ltd
- MiCo Ceramics
- Fralock (Oasis Materials)
- Sumitomo Electric
What is the 10-year outlook for the global Semiconductor Pedestals market?
What factors are driving Semiconductor Pedestals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Semiconductor Pedestals market opportunities vary by end market size?
How does Semiconductor Pedestals break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global On-body Injectors Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for On-body Injectors by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for On-body Injectors by Country/Region, 2020, 2024 & 2031
2.2 On-body Injectors Segment by Type
2.2.1 Electronic Injectors
2.2.2 Mechanical Injectors
2.3 On-body Injectors Sales by Type
2.3.1 Global On-body Injectors Sales Market Share by Type (2020-2025)
2.3.2 Global On-body Injectors Revenue and Market Share by Type (2020-2025)
2.3.3 Global On-body Injectors Sale Price by Type (2020-2025)
2.4 On-body Injectors Segment by Application
2.4.1 Immuno-oncology
2.4.2 Cardiovascular Diseases
2.4.3 Neurological Diseases
2.4.4 Others
2.5 On-body Injectors Sales by Application
2.5.1 Global On-body Injectors Sale Market Share by Application (2020-2025)
2.5.2 Global On-body Injectors Revenue and Market Share by Application (2020-2025)
2.5.3 Global On-body Injectors Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global On-body Injectors Breakdown Data by Company
3.1.1 Global On-body Injectors Annual Sales by Company (2020-2025)
3.1.2 Global On-body Injectors Sales Market Share by Company (2020-2025)
3.2 Global On-body Injectors Annual Revenue by Company (2020-2025)
3.2.1 Global On-body Injectors Revenue by Company (2020-2025)
3.2.2 Global On-body Injectors Revenue Market Share by Company (2020-2025)
3.3 Global On-body Injectors Sale Price by Company
3.4 Key Manufacturers On-body Injectors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers On-body Injectors Product Location Distribution
3.4.2 Players On-body Injectors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ON-BODY INJECTORS BY GEOGRAPHIC REGION
4.1 World Historic On-body Injectors Market Size by Geographic Region (2020-2025)
4.1.1 Global On-body Injectors Annual Sales by Geographic Region (2020-2025)
4.1.2 Global On-body Injectors Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic On-body Injectors Market Size by Country/Region (2020-2025)
4.2.1 Global On-body Injectors Annual Sales by Country/Region (2020-2025)
4.2.2 Global On-body Injectors Annual Revenue by Country/Region (2020-2025)
4.3 Americas On-body Injectors Sales Growth
4.4 APAC On-body Injectors Sales Growth
4.5 Europe On-body Injectors Sales Growth
4.6 Middle East & Africa On-body Injectors Sales Growth
5 AMERICAS
5.1 Americas On-body Injectors Sales by Country
5.1.1 Americas On-body Injectors Sales by Country (2020-2025)
5.1.2 Americas On-body Injectors Revenue by Country (2020-2025)
5.2 Americas On-body Injectors Sales by Type (2020-2025)
5.3 Americas On-body Injectors Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC On-body Injectors Sales by Region
6.1.1 APAC On-body Injectors Sales by Region (2020-2025)
6.1.2 APAC On-body Injectors Revenue by Region (2020-2025)
6.2 APAC On-body Injectors Sales by Type (2020-2025)
6.3 APAC On-body Injectors Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe On-body Injectors by Country
7.1.1 Europe On-body Injectors Sales by Country (2020-2025)
7.1.2 Europe On-body Injectors Revenue by Country (2020-2025)
7.2 Europe On-body Injectors Sales by Type (2020-2025)
7.3 Europe On-body Injectors Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa On-body Injectors by Country
8.1.1 Middle East & Africa On-body Injectors Sales by Country (2020-2025)
8.1.2 Middle East & Africa On-body Injectors Revenue by Country (2020-2025)
8.2 Middle East & Africa On-body Injectors Sales by Type (2020-2025)
8.3 Middle East & Africa On-body Injectors Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of On-body Injectors
10.3 Manufacturing Process Analysis of On-body Injectors
10.4 Industry Chain Structure of On-body Injectors
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 On-body Injectors Distributors
11.3 On-body Injectors Customer
12 WORLD FORECAST REVIEW FOR ON-BODY INJECTORS BY GEOGRAPHIC REGION
12.1 Global On-body Injectors Market Size Forecast by Region
12.1.1 Global On-body Injectors Forecast by Region (2026-2031)
12.1.2 Global On-body Injectors Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global On-body Injectors Forecast by Type (2026-2031)
12.7 Global On-body Injectors Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 West Pharmaceutical Services
13.1.1 West Pharmaceutical Services Company Information
13.1.2 West Pharmaceutical Services On-body Injectors Product Portfolios and Specifications
13.1.3 West Pharmaceutical Services On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 West Pharmaceutical Services Main Business Overview
13.1.5 West Pharmaceutical Services Latest Developments
13.2 Insulet
13.2.1 Insulet Company Information
13.2.2 Insulet On-body Injectors Product Portfolios and Specifications
13.2.3 Insulet On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Insulet Main Business Overview
13.2.5 Insulet Latest Developments
13.3 Gerresheimer
13.3.1 Gerresheimer Company Information
13.3.2 Gerresheimer On-body Injectors Product Portfolios and Specifications
13.3.3 Gerresheimer On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Gerresheimer Main Business Overview
13.3.5 Gerresheimer Latest Developments
13.4 United Therapeutics
13.4.1 United Therapeutics Company Information
13.4.2 United Therapeutics On-body Injectors Product Portfolios and Specifications
13.4.3 United Therapeutics On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 United Therapeutics Main Business Overview
13.4.5 United Therapeutics Latest Developments
13.5 CC Bio
13.5.1 CC Bio Company Information
13.5.2 CC Bio On-body Injectors Product Portfolios and Specifications
13.5.3 CC Bio On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 CC Bio Main Business Overview
13.5.5 CC Bio Latest Developments
13.6 BD
13.6.1 BD Company Information
13.6.2 BD On-body Injectors Product Portfolios and Specifications
13.6.3 BD On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 BD Main Business Overview
13.6.5 BD Latest Developments
13.7 Ypsomed
13.7.1 Ypsomed Company Information
13.7.2 Ypsomed On-body Injectors Product Portfolios and Specifications
13.7.3 Ypsomed On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Ypsomed Main Business Overview
13.7.5 Ypsomed Latest Developments
13.8 Enable Injections
13.8.1 Enable Injections Company Information
13.8.2 Enable Injections On-body Injectors Product Portfolios and Specifications
13.8.3 Enable Injections On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Enable Injections Main Business Overview
13.8.5 Enable Injections Latest Developments
13.9 Nemera
13.9.1 Nemera Company Information
13.9.2 Nemera On-body Injectors Product Portfolios and Specifications
13.9.3 Nemera On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Nemera Main Business Overview
13.9.5 Nemera Latest Developments
13.10 Stevanato Group
13.10.1 Stevanato Group Company Information
13.10.2 Stevanato Group On-body Injectors Product Portfolios and Specifications
13.10.3 Stevanato Group On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Stevanato Group Main Business Overview
13.10.5 Stevanato Group Latest Developments
13.11 Sonceboz
13.11.1 Sonceboz Company Information
13.11.2 Sonceboz On-body Injectors Product Portfolios and Specifications
13.11.3 Sonceboz On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Sonceboz Main Business Overview
13.11.5 Sonceboz Latest Developments
13.12 Lohmann Therapie-Systeme
13.12.1 Lohmann Therapie-Systeme Company Information
13.12.2 Lohmann Therapie-Systeme On-body Injectors Product Portfolios and Specifications
13.12.3 Lohmann Therapie-Systeme On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Lohmann Therapie-Systeme Main Business Overview
13.12.5 Lohmann Therapie-Systeme Latest Developments
13.13 Elcam Drug Delivery Devices (E3D)
13.13.1 Elcam Drug Delivery Devices (E3D) Company Information
13.13.2 Elcam Drug Delivery Devices (E3D) On-body Injectors Product Portfolios and Specifications
13.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Elcam Drug Delivery Devices (E3D) Main Business Overview
13.13.5 Elcam Drug Delivery Devices (E3D) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global On-body Injectors Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for On-body Injectors by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for On-body Injectors by Country/Region, 2020, 2024 & 2031
2.2 On-body Injectors Segment by Type
2.2.1 Electronic Injectors
2.2.2 Mechanical Injectors
2.3 On-body Injectors Sales by Type
2.3.1 Global On-body Injectors Sales Market Share by Type (2020-2025)
2.3.2 Global On-body Injectors Revenue and Market Share by Type (2020-2025)
2.3.3 Global On-body Injectors Sale Price by Type (2020-2025)
2.4 On-body Injectors Segment by Application
2.4.1 Immuno-oncology
2.4.2 Cardiovascular Diseases
2.4.3 Neurological Diseases
2.4.4 Others
2.5 On-body Injectors Sales by Application
2.5.1 Global On-body Injectors Sale Market Share by Application (2020-2025)
2.5.2 Global On-body Injectors Revenue and Market Share by Application (2020-2025)
2.5.3 Global On-body Injectors Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global On-body Injectors Breakdown Data by Company
3.1.1 Global On-body Injectors Annual Sales by Company (2020-2025)
3.1.2 Global On-body Injectors Sales Market Share by Company (2020-2025)
3.2 Global On-body Injectors Annual Revenue by Company (2020-2025)
3.2.1 Global On-body Injectors Revenue by Company (2020-2025)
3.2.2 Global On-body Injectors Revenue Market Share by Company (2020-2025)
3.3 Global On-body Injectors Sale Price by Company
3.4 Key Manufacturers On-body Injectors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers On-body Injectors Product Location Distribution
3.4.2 Players On-body Injectors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ON-BODY INJECTORS BY GEOGRAPHIC REGION
4.1 World Historic On-body Injectors Market Size by Geographic Region (2020-2025)
4.1.1 Global On-body Injectors Annual Sales by Geographic Region (2020-2025)
4.1.2 Global On-body Injectors Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic On-body Injectors Market Size by Country/Region (2020-2025)
4.2.1 Global On-body Injectors Annual Sales by Country/Region (2020-2025)
4.2.2 Global On-body Injectors Annual Revenue by Country/Region (2020-2025)
4.3 Americas On-body Injectors Sales Growth
4.4 APAC On-body Injectors Sales Growth
4.5 Europe On-body Injectors Sales Growth
4.6 Middle East & Africa On-body Injectors Sales Growth
5 AMERICAS
5.1 Americas On-body Injectors Sales by Country
5.1.1 Americas On-body Injectors Sales by Country (2020-2025)
5.1.2 Americas On-body Injectors Revenue by Country (2020-2025)
5.2 Americas On-body Injectors Sales by Type (2020-2025)
5.3 Americas On-body Injectors Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC On-body Injectors Sales by Region
6.1.1 APAC On-body Injectors Sales by Region (2020-2025)
6.1.2 APAC On-body Injectors Revenue by Region (2020-2025)
6.2 APAC On-body Injectors Sales by Type (2020-2025)
6.3 APAC On-body Injectors Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe On-body Injectors by Country
7.1.1 Europe On-body Injectors Sales by Country (2020-2025)
7.1.2 Europe On-body Injectors Revenue by Country (2020-2025)
7.2 Europe On-body Injectors Sales by Type (2020-2025)
7.3 Europe On-body Injectors Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa On-body Injectors by Country
8.1.1 Middle East & Africa On-body Injectors Sales by Country (2020-2025)
8.1.2 Middle East & Africa On-body Injectors Revenue by Country (2020-2025)
8.2 Middle East & Africa On-body Injectors Sales by Type (2020-2025)
8.3 Middle East & Africa On-body Injectors Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of On-body Injectors
10.3 Manufacturing Process Analysis of On-body Injectors
10.4 Industry Chain Structure of On-body Injectors
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 On-body Injectors Distributors
11.3 On-body Injectors Customer
12 WORLD FORECAST REVIEW FOR ON-BODY INJECTORS BY GEOGRAPHIC REGION
12.1 Global On-body Injectors Market Size Forecast by Region
12.1.1 Global On-body Injectors Forecast by Region (2026-2031)
12.1.2 Global On-body Injectors Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global On-body Injectors Forecast by Type (2026-2031)
12.7 Global On-body Injectors Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 West Pharmaceutical Services
13.1.1 West Pharmaceutical Services Company Information
13.1.2 West Pharmaceutical Services On-body Injectors Product Portfolios and Specifications
13.1.3 West Pharmaceutical Services On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 West Pharmaceutical Services Main Business Overview
13.1.5 West Pharmaceutical Services Latest Developments
13.2 Insulet
13.2.1 Insulet Company Information
13.2.2 Insulet On-body Injectors Product Portfolios and Specifications
13.2.3 Insulet On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Insulet Main Business Overview
13.2.5 Insulet Latest Developments
13.3 Gerresheimer
13.3.1 Gerresheimer Company Information
13.3.2 Gerresheimer On-body Injectors Product Portfolios and Specifications
13.3.3 Gerresheimer On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Gerresheimer Main Business Overview
13.3.5 Gerresheimer Latest Developments
13.4 United Therapeutics
13.4.1 United Therapeutics Company Information
13.4.2 United Therapeutics On-body Injectors Product Portfolios and Specifications
13.4.3 United Therapeutics On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 United Therapeutics Main Business Overview
13.4.5 United Therapeutics Latest Developments
13.5 CC Bio
13.5.1 CC Bio Company Information
13.5.2 CC Bio On-body Injectors Product Portfolios and Specifications
13.5.3 CC Bio On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 CC Bio Main Business Overview
13.5.5 CC Bio Latest Developments
13.6 BD
13.6.1 BD Company Information
13.6.2 BD On-body Injectors Product Portfolios and Specifications
13.6.3 BD On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 BD Main Business Overview
13.6.5 BD Latest Developments
13.7 Ypsomed
13.7.1 Ypsomed Company Information
13.7.2 Ypsomed On-body Injectors Product Portfolios and Specifications
13.7.3 Ypsomed On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Ypsomed Main Business Overview
13.7.5 Ypsomed Latest Developments
13.8 Enable Injections
13.8.1 Enable Injections Company Information
13.8.2 Enable Injections On-body Injectors Product Portfolios and Specifications
13.8.3 Enable Injections On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Enable Injections Main Business Overview
13.8.5 Enable Injections Latest Developments
13.9 Nemera
13.9.1 Nemera Company Information
13.9.2 Nemera On-body Injectors Product Portfolios and Specifications
13.9.3 Nemera On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Nemera Main Business Overview
13.9.5 Nemera Latest Developments
13.10 Stevanato Group
13.10.1 Stevanato Group Company Information
13.10.2 Stevanato Group On-body Injectors Product Portfolios and Specifications
13.10.3 Stevanato Group On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Stevanato Group Main Business Overview
13.10.5 Stevanato Group Latest Developments
13.11 Sonceboz
13.11.1 Sonceboz Company Information
13.11.2 Sonceboz On-body Injectors Product Portfolios and Specifications
13.11.3 Sonceboz On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Sonceboz Main Business Overview
13.11.5 Sonceboz Latest Developments
13.12 Lohmann Therapie-Systeme
13.12.1 Lohmann Therapie-Systeme Company Information
13.12.2 Lohmann Therapie-Systeme On-body Injectors Product Portfolios and Specifications
13.12.3 Lohmann Therapie-Systeme On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Lohmann Therapie-Systeme Main Business Overview
13.12.5 Lohmann Therapie-Systeme Latest Developments
13.13 Elcam Drug Delivery Devices (E3D)
13.13.1 Elcam Drug Delivery Devices (E3D) Company Information
13.13.2 Elcam Drug Delivery Devices (E3D) On-body Injectors Product Portfolios and Specifications
13.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Elcam Drug Delivery Devices (E3D) Main Business Overview
13.13.5 Elcam Drug Delivery Devices (E3D) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. On-body Injectors Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. On-body Injectors Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Electronic Injectors
Table 4. Major Players of Mechanical Injectors
Table 5. Global On-body Injectors Sales by Type (2020-2025) & (K Units)
Table 6. Global On-body Injectors Sales Market Share by Type (2020-2025)
Table 7. Global On-body Injectors Revenue by Type (2020-2025) & ($ million)
Table 8. Global On-body Injectors Revenue Market Share by Type (2020-2025)
Table 9. Global On-body Injectors Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global On-body Injectors Sale by Application (2020-2025) & (K Units)
Table 11. Global On-body Injectors Sale Market Share by Application (2020-2025)
Table 12. Global On-body Injectors Revenue by Application (2020-2025) & ($ million)
Table 13. Global On-body Injectors Revenue Market Share by Application (2020-2025)
Table 14. Global On-body Injectors Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global On-body Injectors Sales by Company (2020-2025) & (K Units)
Table 16. Global On-body Injectors Sales Market Share by Company (2020-2025)
Table 17. Global On-body Injectors Revenue by Company (2020-2025) & ($ millions)
Table 18. Global On-body Injectors Revenue Market Share by Company (2020-2025)
Table 19. Global On-body Injectors Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers On-body Injectors Producing Area Distribution and Sales Area
Table 21. Players On-body Injectors Products Offered
Table 22. On-body Injectors Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global On-body Injectors Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global On-body Injectors Sales Market Share Geographic Region (2020-2025)
Table 27. Global On-body Injectors Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global On-body Injectors Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global On-body Injectors Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global On-body Injectors Sales Market Share by Country/Region (2020-2025)
Table 31. Global On-body Injectors Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global On-body Injectors Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas On-body Injectors Sales by Country (2020-2025) & (K Units)
Table 34. Americas On-body Injectors Sales Market Share by Country (2020-2025)
Table 35. Americas On-body Injectors Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas On-body Injectors Sales by Type (2020-2025) & (K Units)
Table 37. Americas On-body Injectors Sales by Application (2020-2025) & (K Units)
Table 38. APAC On-body Injectors Sales by Region (2020-2025) & (K Units)
Table 39. APAC On-body Injectors Sales Market Share by Region (2020-2025)
Table 40. APAC On-body Injectors Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC On-body Injectors Sales by Type (2020-2025) & (K Units)
Table 42. APAC On-body Injectors Sales by Application (2020-2025) & (K Units)
Table 43. Europe On-body Injectors Sales by Country (2020-2025) & (K Units)
Table 44. Europe On-body Injectors Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe On-body Injectors Sales by Type (2020-2025) & (K Units)
Table 46. Europe On-body Injectors Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa On-body Injectors Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa On-body Injectors Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa On-body Injectors Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa On-body Injectors Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of On-body Injectors
Table 52. Key Market Challenges & Risks of On-body Injectors
Table 53. Key Industry Trends of On-body Injectors
Table 54. On-body Injectors Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. On-body Injectors Distributors List
Table 57. On-body Injectors Customer List
Table 58. Global On-body Injectors Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global On-body Injectors Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas On-body Injectors Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas On-body Injectors Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC On-body Injectors Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC On-body Injectors Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe On-body Injectors Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe On-body Injectors Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa On-body Injectors Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa On-body Injectors Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global On-body Injectors Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global On-body Injectors Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global On-body Injectors Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global On-body Injectors Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. West Pharmaceutical Services Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 73. West Pharmaceutical Services On-body Injectors Product Portfolios and Specifications
Table 74. West Pharmaceutical Services On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. West Pharmaceutical Services Main Business
Table 76. West Pharmaceutical Services Latest Developments
Table 77. Insulet Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 78. Insulet On-body Injectors Product Portfolios and Specifications
Table 79. Insulet On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Insulet Main Business
Table 81. Insulet Latest Developments
Table 82. Gerresheimer Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 83. Gerresheimer On-body Injectors Product Portfolios and Specifications
Table 84. Gerresheimer On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Gerresheimer Main Business
Table 86. Gerresheimer Latest Developments
Table 87. United Therapeutics Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 88. United Therapeutics On-body Injectors Product Portfolios and Specifications
Table 89. United Therapeutics On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. United Therapeutics Main Business
Table 91. United Therapeutics Latest Developments
Table 92. CC Bio Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 93. CC Bio On-body Injectors Product Portfolios and Specifications
Table 94. CC Bio On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. CC Bio Main Business
Table 96. CC Bio Latest Developments
Table 97. BD Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 98. BD On-body Injectors Product Portfolios and Specifications
Table 99. BD On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. BD Main Business
Table 101. BD Latest Developments
Table 102. Ypsomed Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 103. Ypsomed On-body Injectors Product Portfolios and Specifications
Table 104. Ypsomed On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Ypsomed Main Business
Table 106. Ypsomed Latest Developments
Table 107. Enable Injections Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 108. Enable Injections On-body Injectors Product Portfolios and Specifications
Table 109. Enable Injections On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Enable Injections Main Business
Table 111. Enable Injections Latest Developments
Table 112. Nemera Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 113. Nemera On-body Injectors Product Portfolios and Specifications
Table 114. Nemera On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Nemera Main Business
Table 116. Nemera Latest Developments
Table 117. Stevanato Group Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 118. Stevanato Group On-body Injectors Product Portfolios and Specifications
Table 119. Stevanato Group On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Stevanato Group Main Business
Table 121. Stevanato Group Latest Developments
Table 122. Sonceboz Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 123. Sonceboz On-body Injectors Product Portfolios and Specifications
Table 124. Sonceboz On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Sonceboz Main Business
Table 126. Sonceboz Latest Developments
Table 127. Lohmann Therapie-Systeme Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 128. Lohmann Therapie-Systeme On-body Injectors Product Portfolios and Specifications
Table 129. Lohmann Therapie-Systeme On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Lohmann Therapie-Systeme Main Business
Table 131. Lohmann Therapie-Systeme Latest Developments
Table 132. Elcam Drug Delivery Devices (E3D) Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 133. Elcam Drug Delivery Devices (E3D) On-body Injectors Product Portfolios and Specifications
Table 134. Elcam Drug Delivery Devices (E3D) On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. Elcam Drug Delivery Devices (E3D) Main Business
Table 136. Elcam Drug Delivery Devices (E3D) Latest Developments
Table 1. On-body Injectors Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. On-body Injectors Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Electronic Injectors
Table 4. Major Players of Mechanical Injectors
Table 5. Global On-body Injectors Sales by Type (2020-2025) & (K Units)
Table 6. Global On-body Injectors Sales Market Share by Type (2020-2025)
Table 7. Global On-body Injectors Revenue by Type (2020-2025) & ($ million)
Table 8. Global On-body Injectors Revenue Market Share by Type (2020-2025)
Table 9. Global On-body Injectors Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global On-body Injectors Sale by Application (2020-2025) & (K Units)
Table 11. Global On-body Injectors Sale Market Share by Application (2020-2025)
Table 12. Global On-body Injectors Revenue by Application (2020-2025) & ($ million)
Table 13. Global On-body Injectors Revenue Market Share by Application (2020-2025)
Table 14. Global On-body Injectors Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global On-body Injectors Sales by Company (2020-2025) & (K Units)
Table 16. Global On-body Injectors Sales Market Share by Company (2020-2025)
Table 17. Global On-body Injectors Revenue by Company (2020-2025) & ($ millions)
Table 18. Global On-body Injectors Revenue Market Share by Company (2020-2025)
Table 19. Global On-body Injectors Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers On-body Injectors Producing Area Distribution and Sales Area
Table 21. Players On-body Injectors Products Offered
Table 22. On-body Injectors Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global On-body Injectors Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global On-body Injectors Sales Market Share Geographic Region (2020-2025)
Table 27. Global On-body Injectors Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global On-body Injectors Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global On-body Injectors Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global On-body Injectors Sales Market Share by Country/Region (2020-2025)
Table 31. Global On-body Injectors Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global On-body Injectors Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas On-body Injectors Sales by Country (2020-2025) & (K Units)
Table 34. Americas On-body Injectors Sales Market Share by Country (2020-2025)
Table 35. Americas On-body Injectors Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas On-body Injectors Sales by Type (2020-2025) & (K Units)
Table 37. Americas On-body Injectors Sales by Application (2020-2025) & (K Units)
Table 38. APAC On-body Injectors Sales by Region (2020-2025) & (K Units)
Table 39. APAC On-body Injectors Sales Market Share by Region (2020-2025)
Table 40. APAC On-body Injectors Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC On-body Injectors Sales by Type (2020-2025) & (K Units)
Table 42. APAC On-body Injectors Sales by Application (2020-2025) & (K Units)
Table 43. Europe On-body Injectors Sales by Country (2020-2025) & (K Units)
Table 44. Europe On-body Injectors Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe On-body Injectors Sales by Type (2020-2025) & (K Units)
Table 46. Europe On-body Injectors Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa On-body Injectors Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa On-body Injectors Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa On-body Injectors Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa On-body Injectors Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of On-body Injectors
Table 52. Key Market Challenges & Risks of On-body Injectors
Table 53. Key Industry Trends of On-body Injectors
Table 54. On-body Injectors Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. On-body Injectors Distributors List
Table 57. On-body Injectors Customer List
Table 58. Global On-body Injectors Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global On-body Injectors Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas On-body Injectors Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas On-body Injectors Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC On-body Injectors Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC On-body Injectors Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe On-body Injectors Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe On-body Injectors Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa On-body Injectors Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa On-body Injectors Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global On-body Injectors Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global On-body Injectors Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global On-body Injectors Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global On-body Injectors Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. West Pharmaceutical Services Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 73. West Pharmaceutical Services On-body Injectors Product Portfolios and Specifications
Table 74. West Pharmaceutical Services On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. West Pharmaceutical Services Main Business
Table 76. West Pharmaceutical Services Latest Developments
Table 77. Insulet Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 78. Insulet On-body Injectors Product Portfolios and Specifications
Table 79. Insulet On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Insulet Main Business
Table 81. Insulet Latest Developments
Table 82. Gerresheimer Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 83. Gerresheimer On-body Injectors Product Portfolios and Specifications
Table 84. Gerresheimer On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Gerresheimer Main Business
Table 86. Gerresheimer Latest Developments
Table 87. United Therapeutics Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 88. United Therapeutics On-body Injectors Product Portfolios and Specifications
Table 89. United Therapeutics On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. United Therapeutics Main Business
Table 91. United Therapeutics Latest Developments
Table 92. CC Bio Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 93. CC Bio On-body Injectors Product Portfolios and Specifications
Table 94. CC Bio On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. CC Bio Main Business
Table 96. CC Bio Latest Developments
Table 97. BD Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 98. BD On-body Injectors Product Portfolios and Specifications
Table 99. BD On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. BD Main Business
Table 101. BD Latest Developments
Table 102. Ypsomed Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 103. Ypsomed On-body Injectors Product Portfolios and Specifications
Table 104. Ypsomed On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Ypsomed Main Business
Table 106. Ypsomed Latest Developments
Table 107. Enable Injections Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 108. Enable Injections On-body Injectors Product Portfolios and Specifications
Table 109. Enable Injections On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Enable Injections Main Business
Table 111. Enable Injections Latest Developments
Table 112. Nemera Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 113. Nemera On-body Injectors Product Portfolios and Specifications
Table 114. Nemera On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Nemera Main Business
Table 116. Nemera Latest Developments
Table 117. Stevanato Group Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 118. Stevanato Group On-body Injectors Product Portfolios and Specifications
Table 119. Stevanato Group On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Stevanato Group Main Business
Table 121. Stevanato Group Latest Developments
Table 122. Sonceboz Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 123. Sonceboz On-body Injectors Product Portfolios and Specifications
Table 124. Sonceboz On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Sonceboz Main Business
Table 126. Sonceboz Latest Developments
Table 127. Lohmann Therapie-Systeme Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 128. Lohmann Therapie-Systeme On-body Injectors Product Portfolios and Specifications
Table 129. Lohmann Therapie-Systeme On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Lohmann Therapie-Systeme Main Business
Table 131. Lohmann Therapie-Systeme Latest Developments
Table 132. Elcam Drug Delivery Devices (E3D) Basic Information, On-body Injectors Manufacturing Base, Sales Area and Its Competitors
Table 133. Elcam Drug Delivery Devices (E3D) On-body Injectors Product Portfolios and Specifications
Table 134. Elcam Drug Delivery Devices (E3D) On-body Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. Elcam Drug Delivery Devices (E3D) Main Business
Table 136. Elcam Drug Delivery Devices (E3D) Latest Developments
LIST OF FIGURES
Figure 1. Picture of On-body Injectors
Figure 2. On-body Injectors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global On-body Injectors Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global On-body Injectors Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. On-body Injectors Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. On-body Injectors Sales Market Share by Country/Region (2024)
Figure 10. On-body Injectors Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Electronic Injectors
Figure 12. Product Picture of Mechanical Injectors
Figure 13. Global On-body Injectors Sales Market Share by Type in 2025
Figure 14. Global On-body Injectors Revenue Market Share by Type (2020-2025)
Figure 15. On-body Injectors Consumed in Immuno-oncology
Figure 16. Global On-body Injectors Market: Immuno-oncology (2020-2025) & (K Units)
Figure 17. On-body Injectors Consumed in Cardiovascular Diseases
Figure 18. Global On-body Injectors Market: Cardiovascular Diseases (2020-2025) & (K Units)
Figure 19. On-body Injectors Consumed in Neurological Diseases
Figure 20. Global On-body Injectors Market: Neurological Diseases (2020-2025) & (K Units)
Figure 21. On-body Injectors Consumed in Others
Figure 22. Global On-body Injectors Market: Others (2020-2025) & (K Units)
Figure 23. Global On-body Injectors Sale Market Share by Application (2024)
Figure 24. Global On-body Injectors Revenue Market Share by Application in 2025
Figure 25. On-body Injectors Sales by Company in 2025 (K Units)
Figure 26. Global On-body Injectors Sales Market Share by Company in 2025
Figure 27. On-body Injectors Revenue by Company in 2025 ($ millions)
Figure 28. Global On-body Injectors Revenue Market Share by Company in 2025
Figure 29. Global On-body Injectors Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global On-body Injectors Revenue Market Share by Geographic Region in 2025
Figure 31. Americas On-body Injectors Sales 2020-2025 (K Units)
Figure 32. Americas On-body Injectors Revenue 2020-2025 ($ millions)
Figure 33. APAC On-body Injectors Sales 2020-2025 (K Units)
Figure 34. APAC On-body Injectors Revenue 2020-2025 ($ millions)
Figure 35. Europe On-body Injectors Sales 2020-2025 (K Units)
Figure 36. Europe On-body Injectors Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa On-body Injectors Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa On-body Injectors Revenue 2020-2025 ($ millions)
Figure 39. Americas On-body Injectors Sales Market Share by Country in 2025
Figure 40. Americas On-body Injectors Revenue Market Share by Country (2020-2025)
Figure 41. Americas On-body Injectors Sales Market Share by Type (2020-2025)
Figure 42. Americas On-body Injectors Sales Market Share by Application (2020-2025)
Figure 43. United States On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC On-body Injectors Sales Market Share by Region in 2025
Figure 48. APAC On-body Injectors Revenue Market Share by Region (2020-2025)
Figure 49. APAC On-body Injectors Sales Market Share by Type (2020-2025)
Figure 50. APAC On-body Injectors Sales Market Share by Application (2020-2025)
Figure 51. China On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 55. India On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe On-body Injectors Sales Market Share by Country in 2025
Figure 59. Europe On-body Injectors Revenue Market Share by Country (2020-2025)
Figure 60. Europe On-body Injectors Sales Market Share by Type (2020-2025)
Figure 61. Europe On-body Injectors Sales Market Share by Application (2020-2025)
Figure 62. Germany On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 63. France On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 64. UK On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa On-body Injectors Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa On-body Injectors Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa On-body Injectors Sales Market Share by Application (2020-2025)
Figure 70. Egypt On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of On-body Injectors in 2025
Figure 76. Manufacturing Process Analysis of On-body Injectors
Figure 77. Industry Chain Structure of On-body Injectors
Figure 78. Channels of Distribution
Figure 79. Global On-body Injectors Sales Market Forecast by Region (2026-2031)
Figure 80. Global On-body Injectors Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global On-body Injectors Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global On-body Injectors Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global On-body Injectors Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global On-body Injectors Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of On-body Injectors
Figure 2. On-body Injectors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global On-body Injectors Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global On-body Injectors Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. On-body Injectors Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. On-body Injectors Sales Market Share by Country/Region (2024)
Figure 10. On-body Injectors Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Electronic Injectors
Figure 12. Product Picture of Mechanical Injectors
Figure 13. Global On-body Injectors Sales Market Share by Type in 2025
Figure 14. Global On-body Injectors Revenue Market Share by Type (2020-2025)
Figure 15. On-body Injectors Consumed in Immuno-oncology
Figure 16. Global On-body Injectors Market: Immuno-oncology (2020-2025) & (K Units)
Figure 17. On-body Injectors Consumed in Cardiovascular Diseases
Figure 18. Global On-body Injectors Market: Cardiovascular Diseases (2020-2025) & (K Units)
Figure 19. On-body Injectors Consumed in Neurological Diseases
Figure 20. Global On-body Injectors Market: Neurological Diseases (2020-2025) & (K Units)
Figure 21. On-body Injectors Consumed in Others
Figure 22. Global On-body Injectors Market: Others (2020-2025) & (K Units)
Figure 23. Global On-body Injectors Sale Market Share by Application (2024)
Figure 24. Global On-body Injectors Revenue Market Share by Application in 2025
Figure 25. On-body Injectors Sales by Company in 2025 (K Units)
Figure 26. Global On-body Injectors Sales Market Share by Company in 2025
Figure 27. On-body Injectors Revenue by Company in 2025 ($ millions)
Figure 28. Global On-body Injectors Revenue Market Share by Company in 2025
Figure 29. Global On-body Injectors Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global On-body Injectors Revenue Market Share by Geographic Region in 2025
Figure 31. Americas On-body Injectors Sales 2020-2025 (K Units)
Figure 32. Americas On-body Injectors Revenue 2020-2025 ($ millions)
Figure 33. APAC On-body Injectors Sales 2020-2025 (K Units)
Figure 34. APAC On-body Injectors Revenue 2020-2025 ($ millions)
Figure 35. Europe On-body Injectors Sales 2020-2025 (K Units)
Figure 36. Europe On-body Injectors Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa On-body Injectors Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa On-body Injectors Revenue 2020-2025 ($ millions)
Figure 39. Americas On-body Injectors Sales Market Share by Country in 2025
Figure 40. Americas On-body Injectors Revenue Market Share by Country (2020-2025)
Figure 41. Americas On-body Injectors Sales Market Share by Type (2020-2025)
Figure 42. Americas On-body Injectors Sales Market Share by Application (2020-2025)
Figure 43. United States On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC On-body Injectors Sales Market Share by Region in 2025
Figure 48. APAC On-body Injectors Revenue Market Share by Region (2020-2025)
Figure 49. APAC On-body Injectors Sales Market Share by Type (2020-2025)
Figure 50. APAC On-body Injectors Sales Market Share by Application (2020-2025)
Figure 51. China On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 55. India On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe On-body Injectors Sales Market Share by Country in 2025
Figure 59. Europe On-body Injectors Revenue Market Share by Country (2020-2025)
Figure 60. Europe On-body Injectors Sales Market Share by Type (2020-2025)
Figure 61. Europe On-body Injectors Sales Market Share by Application (2020-2025)
Figure 62. Germany On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 63. France On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 64. UK On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa On-body Injectors Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa On-body Injectors Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa On-body Injectors Sales Market Share by Application (2020-2025)
Figure 70. Egypt On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries On-body Injectors Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of On-body Injectors in 2025
Figure 76. Manufacturing Process Analysis of On-body Injectors
Figure 77. Industry Chain Structure of On-body Injectors
Figure 78. Channels of Distribution
Figure 79. Global On-body Injectors Sales Market Forecast by Region (2026-2031)
Figure 80. Global On-body Injectors Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global On-body Injectors Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global On-body Injectors Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global On-body Injectors Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global On-body Injectors Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Abdominal Aortic Aneurysm (AAA) Repair Devices Market Growth 2024-2030
US$ 3,660.00
February 2024
110 pages
Global Natriuretic Peptides Test Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
76 pages
Global Canagliflozin Market Growth 2023-2029
US$ 3,660.00
March 2023
77 pages
Global Laboratory Baths Market Growth 2024-2030
US$ 3,660.00
February 2024
162 pages
Global Local Anesthesia Drugs Market Growth 2025-2031
US$ 3,660.00
October 2025
103 pages
